Ikarian Capital, LLC Sensei Biotherapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 449,963 shares of SNSE stock, worth $134,988. This represents 0.02% of its overall portfolio holdings.
Number of Shares
449,963
Previous 649,963
30.77%
Holding current value
$134,988
Previous $324,000
45.99%
% of portfolio
0.02%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding SNSE
# of Institutions
23Shares Held
1.97MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA586KShares$175,6720.0% of portfolio
-
Catalio Capital Management, LP New York, NY294KShares$88,3120.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny177KShares$53,1900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$45,2120.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY109KShares$32,5970.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $9.22M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...